https://sdktx.com/sdk-therapeutics-announces-completion-of-enrollment-in-the-pharmacokinetic-trial-of-sdk001-oral-solution-of-arsenic-trioxide-in-patients-with-acute-promyelocytic-leukemia/ 2025-11-04T16:01:29+00:00 https://sdktx.com/sdk-therapeutics-announcesposter-presentation-of-oral-arsenic-trioxide-at-the-67thamerican-society-of-hematology-ash-annual-meeting/ 2025-11-04T17:12:13+00:00